Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

Clinical trial NCT06333509 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06333509
Sponsor: CARsgen Therapeutics Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Primary Plasma Cell Leukemia

Start date: 2024-04-15
Primary completion: 2027-06-15
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.